June 9, 2026 POET Technologies, Inc. Investors Have Until June 29th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
June 9, 2026 Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
